| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | BIOTECNOLOGÍA | 49,61% | 8,72% | -30,16% | · |
| NATIXIS ASIA EQUITY I/A (EUR) | RVI ASIA EX-JAPÓN | 49,61% | 48,82% | 11,86% | 90,89% |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND AI-EUR | RVI EMERGENTES | 49,61% | 46,30% | 2,17% | · |
| SCHRODER ISF JAPANESE EQUITY A1 ACC USD (HEDGED) | RVI JAPÓN | 49,61% | 80,33% | 99,76% | 197,97% |
| BARINGS GLOBAL EMERGING MARKETS FUND A GBP DIS | RVI EMERGENTES | 49,60% | 47,77% | 27,65% | 113,40% |
| BGF WORLD TECHNOLOGY A2 SGD (HEDGED) | TMT | 49,58% | 97,07% | 48,27% | · |
| GOLDMAN SACHS MULTI-MANAGER EMERGING MARKETS EQUITY PORTFOLIO I CAP USD | RVI EMERGENTES | 49,57% | 65,49% | 35,20% | 122,53% |
| INVESCO TECHNOLOGY S&P US SELECT SECTOR UCITS ETF ACC | TMT | 49,57% | 124,63% | 151,87% | 706,48% |
| NORDEA 1-EMERGING SUSTAINABLE STARS EQUITY FUND E-EUR | RVI EMERGENTES | 49,57% | 47,87% | 2,71% | 101,60% |
| T.ROWE EMERGING MARKETS EQUITY FUND A (EUR) | RVI EMERGENTES | 49,57% | 29,50% | -3,52% | · |
